Cargando…
Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes
BACKGROUND: Escalating trends of obesity and associated type 2 diabetes (T2D) has prompted an increase in the use of alternative and complementary functional foods. Momordica charantia or bitter melon (BM) that is traditionally used to treat diabetes and complications has been demonstrated to allevi...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911406/ https://www.ncbi.nlm.nih.gov/pubmed/20587058 http://dx.doi.org/10.1186/1472-6882-10-34 |